<DOC>
	<DOC>NCT02105376</DOC>
	<brief_summary>This is a phase II, randomized, sham controlled, clinical trial. This clinical trial has as primary objective to evaluate the effect of the Trigeminal Nerve Stimulation (TNS) on depressive symptoms measured by the Hamilton Depressive Rating Scale version 17 items (HDRS-17) in patients with moderate / severe depressive episode.</brief_summary>
	<brief_title>TNS for Major Depressive Disorder: a Phase II Randomized Controlled Trial</brief_title>
	<detailed_description />
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder, Major</mesh_term>
	<criteria>1. patients between 18 and 69 years 2. patients with a diagnosis of depression according to the SCID 3. score greater than or equal to 18 on the Hamilton Rating Scale 17item version (equivalent to moderate or severe depressive episode) 4. agreement to participate in the study as recommended in the IC. 1. patients with psychiatric indication for hospitalization 2. patients with psychiatric comorbidity 3. patients with a diagnosis of personality disorder 4. presence of severe neurological or medical diseases such as neoplasms in activity, neurodegenerative diseases and chronic diseases uncompensated.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>69 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>depression</keyword>
	<keyword>cranial nerve stimulation</keyword>
	<keyword>trigeminal stimulation</keyword>
</DOC>